Nanotechnology Now - Press Release: BioForce Nanosciences Technology Spreading Overseas to Italy

Home > Press > BioForce Nanosciences Technology Spreading Overseas to Italy

Abstract:
BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings,
Inc.(OTC Bulletin Board: BFNH), announces today the March sale of the Nano
eNabler(TM) molecular printer to the National Nanotechnology Laboratory of
Research Council-National Institute for the Physics of Matter (CNR-INFM) in
Lecce, Italy. The laboratory is a cross-discipline nanotechnology facility
for nanometer scale research and technology that operates at the University
of Lecce. The Nano eNabler system will be specifically used by Dr. Franco
Calabi, a researcher at the laboratory. Dr. Calabi will be using the Nano
eNabler technology to pattern biomolecules for hybrid bioelectric and
lab-on-chip devices and implementing DNA and protein microarrays.

BioForce Nanosciences Technology Spreading Overseas to Italy

AMES, IA | Posted on March 23rd, 2007

The Nano eNabler system -- BioForce's flagship product -- is a benchtop
molecular printer that places tiny drops of liquid onto surfaces with
nanometer spatial precision. The CNR-INFM is a top academic research lab,
with a worldwide reputation for its many activities in the nanotechnology
area, as documented by their publication record. When asked why the Nano
eNabler system was appealing to Dr. Calabi's research, he explained, "The
resolution it provides and the variety of substrates and materials suitable
for printing."

"I'm excited to see the Nano eNabler technology spread overseas at such
a fast rate," notes Kerry Frey, BioForce's chief operating officer. "It's
obvious the Nano eNabler molecular printer is filling a void that previous
technology did not fulfill."

####

About BioForce Nanosciences
BioForce Nanosciences, Inc. is a wholly owned subsidiary of BioForce
Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH). BioForce
Nanosciences is a unique company entering into commercialization with over
a decade of research and accomplishment in the field of bionanotechnology.
BioForce has demonstrated the ability to take a product from concept to
commercial sale. For more information, visit http://www.bioforcenano.com .

This news release contains forward-looking information that may be
affected by certain risks and uncertainties, including those risks and
uncertainties described in the Company's most recent filings with the
Securities and Exchange Commission. The Company's actual results could
differ materially from such forward-looking statements. We assume no duty
to update these statements at any future date.

For more information, please click here

Contacts:
BioForce Nanosciences, Inc.
1615 Golden Aspen Drive, Suite 101
Ames, IA 50010 USA

Phone: 515.233.8333
Fax: 515.233.8337
E-mail:

Investor Relations
Phone: 515.233.8333 ext. 101
Fax: 515.233.8337
E-mail:

US Sales & Distributor Service
Phone: 515.233.8333
Fax: 515.233.8337 3xt. 127
E-mail Contacts: